CTT Pharmaceutical Holdings: CEO bought 3,700 shares

What happened The filing lists CTT Pharmaceutical Holdings, Inc. (CEO, director) as acquiring 3,700 shares in an open market or private purchase at $0.06 per share on Oct 6, 2026, for $204. The report was filed on Oct 6, 2026.

Key details

• Transaction date and price: Oct 6, 2026 — purchase at $0.06 per share (transaction code P).
• Total acquired and value: 3,700 shares for $204.
• Shares owned after the transaction: not reported in the filing.
• Footnotes/plans: the filing does not report a 10b5-1 plan, tax withholding, or other footnotes.
• Filing date and timeliness: form filed on Oct 6, 2026 (the same day as the reported transaction).

Why it may matter

• This was a purchase (open market or private purchase), not an option exercise or a gift.
• A filing does not show why the insider traded or why the company acted.